IWPC Sample Set Credits (GAP-JAPAN)

International Warfarin Pharmacogenomics Consortium (IWPC) sample sets:
 
A number of pharmacogenomics research centers have collected data sets relating warfarin dosing to a variety of clinical and genetic parameters including genotypes of CYP2C9 and VKORC1. There is an interest among these groups in sharing their data, in order to possibly arrive at a consensus model for dosing that is consistent with all data sets. For further information regarding the warfarin consortium, please send e-mail to feedback@pharmgkb.org.
 
IWPC Team
 
Data Contributors
 
  • Academic Sinica, Taiwan, ROC:
    Ming-Ta M. Lee, Yuan-Tsong Chen
  • Chang Gung Memorial Hospital, Chang Gung University, Taiwan, ROC:
    Ming-Shien Wen
  • Hadassah Medical Organization, Israel:
    Yoseph Caraco, Idit Achache, Simha Blotnick, Mordechai Muszkat
  • Inje University, Korea:
    Jae-Gook Shin, Ho-Sook Kim
  • Instituto Nacional de Câncer, Brazil:
    Guilherme Suarez-Kurtz, Jamila Alessandra Perini, Edimilson A. Silva
  • Intermountain Healthcare, USA:
    Jeffrey Anderson, Benjamin Horne, John Carlquist
  • Marshfield Clinic, USA:
    Michael D. Caldwell, Richard L. Berg, James K. Burmester
  • National University Hospital, Singapore:
    Boon Cher Goh, Soo-Chin Lee
  • Newcastle University, United Kingdom:
    Farhad Kamali, Elizabeth Sconce, Ann Daly
  • University of Alabama, USA:
    Nita Limdi
  • University of California, San Francisco, USA:
    Alan Wu
  • University of Florida, USA:
    Julie A. Johnson, Taimour Y. Langaee, Hua Feng
  • University of Illinois, Chicago, USA:
    Larisa Cavallari, Kathryn Momary
  • University of Liverpool, United Kingdom:
    Munir Pirmohamed, Andrea Jorgensen, Cheng Hok Toh, Paula Williamson
  • University of North Carolina, USA:
    Howard McLeod, James P. Evans, Karen E. Weck
  • University of Pennsylvania, USA:
    Stephen Kimmel, Colleen Brensinger
  • University of Tokyo and RIKEN, Japan:
    Yusuke Nakamura, Taisei Mushiroda
  • University of Washington, USA:
    David Veenstra, Lisa Meckley, Mark Rieder, Allan Rettie
  • Uppsala University, Sweden:
    Mia Wadelius, Niclas Eriksson
  • Vanderbilt University, USA:
    C. Michael Stein, Dan M. Roden, Ute Schwartz, Daniel Kurnik
  • Washington University in St. Louis, USA:
    Brian Gage, Elena Deych, Petra Lenzini, Charles Eby
  • Wellcome Trust Sanger Institute, United Kingdom:
    Leslie Y. Chen, Panos Deloukas
Statistical Analysis:
 
  • University of Alabama, USA:
    Nita Limdi
  • Marshfield Clinic, USA:
    Michael D. Caldwell
  • North Carolina State University, USA:
    Alison Motsinger-Reif
  • Stanford University, USA:
    Teri E. Klein, Russ B. Altman, Balaji S. Srinivasan
  • Uppsala University, Sweden:
    Niclas Eriksson
  • University of California, San Francisco, USA:
    Alan Wu
  • University of North Carolina, USA:
    Michael Wagner
  • University of Florida, USA:
    Julie A. Johnson
  • University of Pennsylvania, USA:
    Stephen Kimmel
  • University of Wisconsin-Madison, USA:
    David Page, Eric Lantz, Tim Chang
  • Vanderbilt University, USA:
    Marylyn Ritchie
  • Washington University in St. Louis, USA:
    Brian Gage, Elena Deych
Genotyping QC of IWPC Samples:
 
  • Academic Sinica, Taiwan, ROC:
    Ming-Ta M. Lee, Liang-Suei Lu
Data Curation:
 
  • Stanford University, USA:
    Teri E. Klein, Russ B. Altman, Balaji S. Srinivasan
  • Washington University in St. Louis, USA:
    Elena Deych
Funding Acknowledgements:
 
  • Academic Sinica, Taiwan, ROC:
    National Research Program for Genomic Medicine, National Science Council,
    Taiwan (National Clinical Core, NSC95-3112-B-001-010 and National Genotyping
    Center, NSC95-3112-B -001-011)
  • Hadassah Medical Organization, Israel:
    Israeli Science Foundation (789/04), United States - Israel Binational Foundation (2003229), Chief Scientist, Ministry of Health (5745)
  • Inje University, Korea:
    KOSEF / MOST (No. R13-2007-023-00000-0) and Korea Health 21 R&D Project, Ministry of Health and Welfare, Korea (A030001)
  • Instituto Nacional de Câncer, Brazil:
    Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundaçço de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
  • Newcastle University, United Kingdom:
    National Health Service (NHS) Executive (Northern & Yorkshire)
  • Stanford University, USA:
    NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374)
  • University of Alabama, USA:
    NIH/NINDS (K23NS45598-01)
  • University of Florida, USA:
    NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM074492)
  • University of Illinois, Chicago, USA:
    the American Association of Colleges of Pharmacy and the American Foundation for Pharmaceutical Education
  • University of Liverpool, United Kingdom:
    United Kingdom Department of Health
  • University of North Carolina, USA:
    NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM63340) and
    North Carolina Biotechnology Company Multidisciplinary Research Grant (2006-MRG-1117)
  • University of Pennsylvania, USA:
    NIH (R01HL066176, P20RR020741 and K24HL070936)
  • University of Washington, USA:
    NIH/NIGMS (GM68797 and GM32165), NIH/NINDS (NS053646), CDC National Office of
    Public Health Genomics (NOPHG) Seed Funding, University of Washington Drug Metabolism, Transport and Pharmacogenomics Research (DMTPR) Program
  • Uppsala University, Sweden:
    Wellcome Trust, Swedish Funding agencies: the Society of Medicine, the Foundation for Strategic Research, the Heart and Lung Foundation, the Söderberg, Thuréus and Selander Foundations and the Clinical Research Support (ALF)
  • Vanderbilt University, USA:
    NIH/NIGMS Pharmacogenetics Research Network and Database (U01HL65962)
  • Washington University in St. Louis, USA:
    NIH (R01HL074724 and R01HL71083), American Heart Association

 

Back to Acknowledgements (GAP-JAPAN)